Emoto, Noriaki ORCID: 0000-0001-6673-2616, Vignon-Zellweger, Nicolas ORCID: 0000-0001-6918-0183, Moreira Lopes, Rheure Alves, Cacioppo, Joseph ORCID: 0000-0002-9763-9139, Desbiens, Louisane, Kamato, Danielle ORCID: 0000-0002-1089-2829, Leurgans, Thomas ORCID: 0000-0001-6912-3699, Moorhouse, Rebecca, Straube, Julia, Wurm, Raphael ORCID: 0000-0003-3027-7775, Heiden, Susi ORCID: 0000-0001-8993-7120, Ergul, Adviye, Yanagisawa, Masashi and Barton, Matthias (2014). 25 Years of endothelin research: the next generation. Life Sci., 118 (2). S. 77 - 87. OXFORD: PERGAMON-ELSEVIER SCIENCE LTD. ISSN 1879-0631

Full text not available from this repository.

Abstract

In the past three decades, endothelin and endothelin receptor antagonists have received great scientific and clinical interest, leading to the publication of more than 27,000 scientific articles since its discovery. The Thirteenth International Conference on Endothelin (ET-13) was held on September 8-11, 2013, at Tokyo Campus of the University of Tsukuba in Japan. Close to 300 scientists from 25 countries from around the world came to Tokyo to celebrate the anniversary of the discovery of the endothelin peptide discovered 25 years ago at the University of Tsukuba. This article summarizes some of the highlights of the conference, the anniversary celebration ceremony, and particularly the participation of next generation of endothelin researchers in endothelin science and the anniversary celebration. As a particular highlight, next generation endothelin researchers wrote a haiku (a traditional form of Japanese poetry originating from consisting of no more than three short verses and 27 on, or Japanese phonetic units) to describe the magic of endothelin science which they presented to the conference audience at the anniversary ceremony. The text of each haiku - both in its original language together with the English translation - is part of this article providing in an exemplary fashion how poetry can be bridged with science. Finally, we give an outlook towards the next 25 years of endothelin research. (C) 2014 Elsevier Inc. All rights reserved.

Item Type: Journal Article
Creators:
CreatorsEmailORCIDORCID Put Code
Emoto, NoriakiUNSPECIFIEDorcid.org/0000-0001-6673-2616UNSPECIFIED
Vignon-Zellweger, NicolasUNSPECIFIEDorcid.org/0000-0001-6918-0183UNSPECIFIED
Moreira Lopes, Rheure AlvesUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Cacioppo, JosephUNSPECIFIEDorcid.org/0000-0002-9763-9139UNSPECIFIED
Desbiens, LouisaneUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Kamato, DanielleUNSPECIFIEDorcid.org/0000-0002-1089-2829UNSPECIFIED
Leurgans, ThomasUNSPECIFIEDorcid.org/0000-0001-6912-3699UNSPECIFIED
Moorhouse, RebeccaUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Straube, JuliaUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Wurm, RaphaelUNSPECIFIEDorcid.org/0000-0003-3027-7775UNSPECIFIED
Heiden, SusiUNSPECIFIEDorcid.org/0000-0001-8993-7120UNSPECIFIED
Ergul, AdviyeUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Yanagisawa, MasashiUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Barton, MatthiasUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
URN: urn:nbn:de:hbz:38-423038
DOI: 10.1016/j.lfs.2014.07.035
Journal or Publication Title: Life Sci.
Volume: 118
Number: 2
Page Range: S. 77 - 87
Date: 2014
Publisher: PERGAMON-ELSEVIER SCIENCE LTD
Place of Publication: OXFORD
ISSN: 1879-0631
Language: English
Faculty: Unspecified
Divisions: Unspecified
Subjects: no entry
Uncontrolled Keywords:
KeywordsLanguage
CHRONIC KIDNEY-DISEASE; VASOCONSTRICTOR PEPTIDE; RECEPTOR ANTAGONISTS; CLINICAL-TRIALS; NITRIC-OXIDE; DISCOVERY; FUTURE; CELLS; HYPERTENSION; SURVIVALMultiple languages
Medicine, Research & Experimental; Pharmacology & PharmacyMultiple languages
URI: http://kups.ub.uni-koeln.de/id/eprint/42303

Downloads

Downloads per month over past year

Altmetric

Export

Actions (login required)

View Item View Item